BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37862725)

  • 21. Chemokine (C-C motif) receptor 2 is associated with the pathological grade and inflammatory response in IgAN children.
    Shen Y; Zhu Z; Wang R; Yan L; Sun S; Lu L; Ren Z; Zhang Q
    BMC Nephrol; 2022 Jun; 23(1):215. PubMed ID: 35725391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y; Li H; Yu H; Wang F; Jia J; Yan T
    BMC Nephrol; 2022 Jan; 23(1):25. PubMed ID: 35016642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy.
    Zhang J; Zhou R; Mi Y; Liu Z; Huang B; Guo R; Wang P; Quan S; Zhou Y
    Kidney Blood Press Res; 2021; 46(3):286-297. PubMed ID: 33866316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydroartemisinin inhibits the proliferation of IgAN mesangial cells through the mTOR signaling pathway.
    Xia M; Liu D; Tang X; Liu Y; Liu H; Liu Y; Chen G; Liu H
    Int Immunopharmacol; 2020 Mar; 80():106125. PubMed ID: 31931362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of PPARα mediates FABP1 expression, contributing to IgA nephropathy by stimulating ferroptosis in human mesangial cells.
    Wu J; Shao X; Shen J; Lin Q; Zhu X; Li S; Li J; Zhou W; Qi C; Ni Z
    Int J Biol Sci; 2022; 18(14):5438-5458. PubMed ID: 36147466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
    Ebefors K; Liu P; Lassén E; Elvin J; Candemark E; Levan K; Haraldsson B; Nyström J
    BMC Nephrol; 2016 Apr; 17():40. PubMed ID: 27044423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
    Oortwijn BD; Roos A; Royle L; van Gijlswijk-Janssen DJ; Faber-Krol MC; Eijgenraam JW; Dwek RA; Daha MR; Rudd PM; van Kooten C
    J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial injury by circulating IgA1 complex through the activation of mesangial cells in IgA nephropathy.
    Huang M; Li X; Zhao L; Ding H; Liu J; Zhu L; Shi S
    Clin Nephrol; 2022 Mar; 97(3):173-182. PubMed ID: 35006072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma fractalkine levels are associated with renal inflammation and outcomes in immunoglobulin A nephropathy.
    Luo R; Guo SM; Li YQ; Yang Y; Li ML; Han M; He XF; Ge SW; Xu G
    Nephrol Dial Transplant; 2019 Sep; 34(9):1549-1558. PubMed ID: 30010903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-species single-cell analysis uncovers the immunopathological mechanisms associated with IgA nephropathy progression.
    Chen X; Wang T; Chen L; Zhao Y; Deng Y; Shen W; Li L; Yin Z; Zhang C; Cai G; Zhang M; Chen X
    JCI Insight; 2024 May; 9(9):. PubMed ID: 38716725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mass spectrometry-based screening identifies circulating immunoglobulinA-α1-microglobulin complex as potential biomarker in immunoglobulin A nephropathy.
    Xu B; Zhu L; Wang Q; Zhao Y; Jia M; Shi S; Liu L; Lv J; Lai W; Ji J; Zhang H
    Nephrol Dial Transplant; 2021 Apr; 36(5):782-792. PubMed ID: 33351144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary levels of chemokines (MCAF/MCP-1, IL-8) reflect distinct disease activities and phases of human IgA nephropathy.
    Yokoyama H; Wada T; Furuichi K; Segawa C; Shimizu M; Kobayashi K; Su S; Mukaida N; Matsushima K
    J Leukoc Biol; 1998 Apr; 63(4):493-9. PubMed ID: 9544580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells.
    Giunti S; Pinach S; Arnaldi L; Viberti G; Perin PC; Camussi G; Gruden G
    Kidney Int; 2006 Mar; 69(5):856-63. PubMed ID: 16518346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-type-specific molecular characterization of cells from circulation and kidney in IgA nephropathy with nephrotic syndrome.
    Chen Q; Jiang H; Ding R; Zhong J; Li L; Wan J; Feng X; Peng L; Yang X; Chen H; Wang A; Jiao J; Yang Q; Chen X; Li X; Shi L; Zhang G; Wang M; Yang H; Li Q
    Front Immunol; 2023; 14():1231937. PubMed ID: 37908345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of CD161+ Vδ1+ γδ T cells in systemic sclerosis: association with interstitial pneumonia.
    Segawa S; Goto D; Horikoshi M; Kondo Y; Umeda N; Hagiwara S; Yokosawa M; Hirota T; Miki H; Tsuboi H; Ogishima H; Suzuki T; Matsumoto I; Sumida T
    Rheumatology (Oxford); 2014 Dec; 53(12):2259-69. PubMed ID: 24972843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptomic and Proteomic Profiling Provides Insight into Mesangial Cell Function in IgA Nephropathy.
    Liu P; Lassén E; Nair V; Berthier CC; Suguro M; Sihlbom C; Kretzler M; Betsholtz C; Haraldsson B; Ju W; Ebefors K; Nyström J
    J Am Soc Nephrol; 2017 Oct; 28(10):2961-2972. PubMed ID: 28646076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
    BMC Nephrol; 2017 Sep; 18(1):301. PubMed ID: 28969604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy.
    Nihei Y; Haniuda K; Higashiyama M; Asami S; Iwasaki H; Fukao Y; Nakayama M; Suzuki H; Kikkawa M; Kazuno S; Miura Y; Suzuki Y; Kitamura D
    Sci Adv; 2023 Mar; 9(12):eadd6734. PubMed ID: 36947618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EIF2α/ATF4 pathway enhances proliferation of mesangial cell via cyclin D1 during endoplasmic reticulum stress in IgA nephropathy.
    Lan Z; Zhao L; Peng L; Wan L; Liu D; Tang C; Chen G; Liu Y; Liu H
    Clin Immunol; 2023 Dec; 257():109840. PubMed ID: 37939913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal Stem Cells Enhance Chemotaxis of Activated T Cells through the CCL2-CCR2 Axis In Vitro.
    Zhang YL; Qiao SK; Xing LN; Guo XN; Ren JH
    Bull Exp Biol Med; 2021 Dec; 172(2):263-269. PubMed ID: 34855085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.